Royalty Pharma plc (NASDAQ:RPRX) Q4 2023 Earnings Call Transcript February 15, 2024 Royalty Pharma plc beats earnings expectations. Reported EPS is $1.15, expectations were $1.01. RPRX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank you for […]
Sunoco LP (NYSE:SUN) Q4 2023 Earnings Call Transcript February 14, 2024 Sunoco LP misses on earnings expectations. Reported EPS is $-1.5 EPS, expectations were $1.01. SUN isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and welcome to Sunoco LP’s […]
Canopy Growth Corporation (NASDAQ:CGC) Q3 2024 Earnings Call Transcript February 9, 2024 Canopy Growth Corporation misses on earnings expectations. Reported EPS is $-1.79 EPS, expectations were $-0.45. CGC isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. My name […]
Qiagen N.V. (NYSE:QGEN) Q4 2023 Earnings Call Transcript February 11, 2024 Qiagen N.V. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day. I’m Melinda, your PGI call operator. Welcome, and thank you for joining Qiagen’s Fourth Quarter 2023 Earnings […]